Related by context. All words. (Click for frequent words.) 73 A3 adenosine receptor 72 VEGF receptor 72 CCR1 72 JAK inhibitors 72 Aurora kinase 71 P#X# 71 CCR2 71 ENMD # 70 CCR9 70 ErbB3 70 chemokine receptor 70 targeting CD# 70 FLT3 70 eIF 4E 70 Wnt signaling pathway 70 preclinically 70 Symadex 70 proteasome inhibitor 70 activin 70 #beta HSD1 70 NS5A 70 HDAC 69 Janus kinase 69 MEK inhibitors 69 selective inhibition 69 Factor VIIa 69 miR #a [002] 69 anticancer therapeutics 69 vascular disrupting agents 69 hedgehog pathway 69 JAK2 inhibitor 69 androgen receptor AR 69 therapeutic monoclonal antibody 69 HDACs 69 C5aR 69 Sym# 68 humanized antibody 68 AEG# 68 JAK2 68 cMET 68 PARP inhibition 68 uPA 68 PKM2 68 mGluR2 NAM 68 HuLuc# 68 c MET 68 JAK kinases 68 TGF β 68 Gleevec resistant 68 thrombin receptor 68 survivin 67 effector function 67 NF kB pathway 67 Nanobody ® 67 ADAMTS# 67 endostatin 67 pDCs 67 tumor antigen 67 therapeutic monoclonal antibodies 67 RNAi therapeutic targeting 67 histone deacetylase HDAC 67 OHR/AVR# 67 MAPK pathway 67 pro angiogenic 67 immunomodulatory 67 IgG1 antibody 67 orally administered inhibitor 67 PARP inhibitors 67 JAK1 67 gamma secretase inhibitor 67 mertansine 67 demethylating agents 67 cytoprotective 67 histone deacetylase inhibitors 67 CYC# 67 immune modulating 67 5 HT4 receptor 67 K ras mutations 67 IGFBP2 67 thrombopoietin 67 mTOR inhibitors 67 Maxy G# 67 immunotoxin 67 receptor tyrosine kinase inhibitor 67 oncogenesis 67 AT1R 67 PROSTVAC VF 67 molecularly targeted 67 siRNA therapeutic 67 OXi# 67 druggable 67 TTR gene 67 interferon lambda 67 Hedgehog pathway 67 TRAIL induced apoptosis 67 IGF 1R 67 TLR8 67 C5a 67 CENP E 67 Panzem 67 neurotrophic factor 67 siRNA therapeutics 67 BRAF inhibitor 67 ASONEP 67 TLR9 agonist 67 CCX# 67 antiangiogenic 67 ProMune 67 COX2 67 Eg5 67 Tyrima 66 E#F# 66 anti CD3 66 Virulizin ® 66 GPR# [002] 66 hedgehog signaling pathway 66 Xanafide 66 OMP #M# 66 small molecule inhibitors 66 engineered RAP peptides 66 immunomodulation 66 Aplidin 66 immunoregulatory 66 nucleoside analogues 66 HSP# inhibitor 66 TLR9 agonists 66 epothilones 66 rBChE 66 Tarvacin 66 antisense oligonucleotide 66 TLR9 66 EndoTAG TM -1 66 mAbs 66 Onconase 66 alpha#beta# integrin 66 cyclin dependent kinases 66 mda 7 66 CEQ# 66 TNFa 66 PI3 kinase 66 glycogen synthase kinase 66 TAp# 66 TGR5 66 poly ADP ribose polymerase 66 HDAC6 66 CXCR7 66 protein kinase inhibitor 66 p# MAPK 66 HER3 66 CD# monoclonal antibody 66 uPAR 66 IMA# 66 Aviptadil 66 CD# antibody [001] 66 FGFR2 66 MEK inhibitor 66 hypoxia inducible factor 66 phosphate S1P 66 cathepsins 66 PKCi 66 monoclonal antibody mAb 66 orally bioavailable 66 HCV polymerase 66 Janus Kinase 66 nicotinic alpha 7 66 antisense inhibitors 66 Protein Kinase C 66 protein tyrosine phosphatase 1B 66 Chemokine 66 JAK inhibitor 66 histone deacetylases 66 MAPK signaling pathway 66 Archexin 66 chemokine receptors 66 microRNA miR 66 cilengitide 66 elotuzumab 66 ALK inhibitor 66 Seliciclib 66 PSMA ADC 66 CA4P 66 ERK1 2 66 anticancer therapies 66 CB2 receptor 66 HCV replication 66 gastrointestinal stromal tumors GISTs 66 tyrosine kinase 66 BCR ABL inhibitors 66 MGd 66 SERMs 66 telomerase activation 66 immunomodulatory properties 66 renal fibrosis 66 Fc fusion protein 66 XmAb# 66 MAb 66 Granulocyte Colony Stimulating Factor 66 Tesmilifene 66 DNA methyltransferases 66 GSK3B 66 tubulin inhibitor 65 Hsp# inhibition 65 ADAM# 65 HDAC3 65 adenoviral 65 Tarvacin TM 65 CYT# potent vascular disrupting 65 depsipeptide 65 p# MAP kinase 65 EGF receptor 65 HSP# inhibitors 65 NS5b 65 flavopiridol 65 selective modulator 65 stem cell pluripotency 65 antitumor 65 PI3K/mTOR 65 Posiphen 65 potent anticancer 65 PTHrP 65 chemopreventive agent 65 AMPK activators 65 Lyn kinase 65 5 HT2C receptor 65 CTLA 4 65 replicon 65 HIF 1α 65 Lenocta 65 PARP inhibitor 65 glucagon receptor 65 HDACi 65 antiproliferative effects 65 GPR# [001] 65 immunomodulator 65 vivo validation 65 miR #a [001] 65 E2F 65 Nanobody 65 enzastaurin 65 hormone gastrin 65 PDE4 inhibitor 65 HCV protease 65 PXD# 65 HQK 65 selective inhibitors 65 gefitinib Iressa 65 PEG SN# 65 immune modulator 65 HDAC inhibitors 65 mTOR inhibition 65 Aurora Kinase 65 investigational therapies 65 thalidomide Thalomid 65 mimetics 65 rxRNA 65 FGFR1 65 NTDDS 65 Bafetinib 65 aurora kinase 65 FGFR 65 anti fibrotic 65 potent antiproliferative 65 tranilast 65 DXL# 65 pan HDAC inhibitor 65 cancer immunotherapies 65 IMC #B 65 Hsp# inhibitors 65 muscarinic 65 sequence homology 65 cellular pathways 65 endogenous ligands 65 DeveloGen 65 cyclin E 65 kinase inhibitors 65 humanized monoclonal antibodies 65 biologic therapeutics 65 Epratuzumab 65 OncoVEX 65 potent inhibition 65 CDK inhibitor 65 Sphingomab 65 PTP 1B 65 HCV protease inhibitors 65 vWF 65 eotaxin 65 antisense drug 65 Epothilones 65 PDGFR 65 novel peptides 65 neuroprotective properties 65 cyclophilin D 65 bioactive lipid 65 BCR ABL 65 PhG alpha 1 65 SGLT2 65 geldanamycin 65 LPA1 65 Six3 65 JAK2 mutation 65 NKT cells 65 Cathepsin S 65 effector functions 65 Vidofludimus 65 γ secretase 65 GKAs 65 selectively inhibits 65 GRN# 65 Ceflatonin 65 Fc receptor 65 c MYC 65 immunostimulatory 65 p# activation 65 tyrosine kinase inhibitor 65 EGFR pathway 65 JAK2 kinase 65 PNP inhibitor 65 mTOR mammalian target 65 glycosylation profile 65 myelofibrosis polycythemia vera 65 OMP #R# 65 ERK signaling 65 therapeutic mAbs 65 DGAT1 64 Tumor Necrosis Factor 64 antisense oligonucleotides 64 adult mesenchymal stem 64 oncolytic 64 GPIIb IIIa 64 radiation sensitizer 64 protein kinases 64 neuropilin 64 EGFr 64 rhIL 7 64 BiTE 64 delta isoform 64 antiapoptotic 64 apoptotic pathway 64 retinoic acid receptor 64 myeloproliferative disorders 64 JAK2 enzyme 64 Galectins 64 Treg cell 64 Skp2 64 chemokine 64 ghrelin antagonist 64 TG# [003] 64 HCD# [002] 64 UCP2 64 YONDELIS 64 Valortim R 64 Prodarsan ® 64 APOPTONE 64 investigational humanized monoclonal antibody 64 CXCR4 receptor 64 chimeric monoclonal antibody 64 MAGE A3 ASCI 64 Squalamine 64 SOD1 64 #ME# 64 kidney urologic 64 Cytochrome P# 64 midstage trials 64 pathophysiological effects 64 RNA silencing 64 CD#L 64 EGFR inhibitors 64 Traficet EN 64 CD# CEA 64 huC# DM4 64 IL 1ß 64 TKM ApoB 64 telomerase inhibitor 64 protein kinase C 64 Maribavir 64 IMC A# 64 sCD# 64 HDAC inhibition 64 small molecule activators 64 SAR# [002] 64 myeloma cells 64 JAK2 inhibitors 64 osteoblast 64 cytokine receptor 64 HGF 64 pomalidomide 64 PDE# 64 glucokinase activator 64 IAP inhibitors 64 obatoclax 64 CDK4 64 R roscovitine 64 adhesion molecule 64 glycosylated 64 AMD# [003] 64 NS4B 64 investigational monoclonal antibody 64 CCR9 antagonist 64 splice variants 64 diagnostic biomarker 64 HER2 receptor 64 alagebrium 64 T#I [002] 64 Thrombin 64 lymphoid cells 64 Zolinza 64 brostallicin 64 HGS ETR2 64 targeting PCSK9 64 serine protease 64 PPARγ 64 Guanilib 64 Angiolix 64 costimulation 64 gastrin 64 novel peptide 64 EGFRvIII 64 humanised monoclonal antibody 64 ENaC 64 cathepsin K 64 GMX# 64 SCD1 64 RAR beta 64 IDH1 64 ALN TTR 64 PI3K inhibitor 64 MDM2 64 Clusterin 64 transient receptor 64 Akt1 64 NNRs 64 interferon IFN 64 LRP5 64 arginase 64 anti CD# antibodies 64 Anticalin R 64 histone deacetylase 64 MUC1 64 anticancer agent 64 ddRNAi 64 novel immunomodulatory 64 microtubule targeting 64 tyrosine phosphorylation 64 HepDirect technology 64 sunitinib malate 64 myeloproliferative diseases 64 Chemokine Receptor 64 melanocortin receptors 64 c myc 64 oncoprotein 64 Vegenics 64 angiogenesis inhibition 64 VitiGam 64 atacicept 64 EGFR HER2 64 NSCLC tumors 64 CDK inhibitors 64 lumiliximab 64 Blinatumomab 64 TRAIL receptor 64 Proxinium TM 64 inverse agonist 64 ATL# [001] 64 humanized monoclonal antibody 64 novel therapeutic antibodies 64 PKC# 64 tipifarnib 64 antibody MAb 64 neurotrophic 64 CCR3 64 orally bioavailable mimics 64 HDAC enzymes 64 Anticalins ® 64 Syk 64 miR #b [001] 64 Immunotherapeutic 64 pharmacological chaperone 64 TGF ß 64 seliciclib 64 Aurora kinase inhibitor 64 antitumoral 64 sphingolipid 64 metalloprotease 64 therapeutic antibody 64 MET amplification 64 ARIKACE ™ 64 MicroRNA 64 cellular immunotherapy 64 alpha7 64 metabotropic glutamate receptors 64 transdifferentiation 64 NEUGENE R 64 anti CD# antibody 64 epothilone 64 TRAF6 64 PDGF receptor 64 Hedgehog signaling pathway 64 vidofludimus 64 splice variant 64 NKX#.# 64 TNFα 64 BRAF kinase 64 M2 subunit 64 STAT3 64 Nanobodies ® 63 phosphatases 63 ERBB4 63 chemically modified siRNA 63 CORT # 63 protein encoded 63 tyrosine kinase receptor 63 oral prodrug 63 immatics 63 Factor VEGF 63 isoform selective 63 KLF4 63 histone deacetylase inhibitor 63 selective kinase inhibitor 63 antidiabetic 63 antisense 63 Vaccinex 63 hematopoietic cells 63 virulence genes 63 PGRN 63 siRNAs targeting 63 cleavable linker 63 TGF alpha 63 TNF α 63 neurite outgrowth 63 glioma cells 63 ALK inhibitors 63 GAP #B# 63 elacytarabine 63 VEGF inhibitors 63 NEUMUNE 63 proto oncogene 63 AGS PSCA 63 Factor Receptor 63 selective agonist 63 Taligen 63 Insegia 63 IMiDs R 63 Akt activation 63 potent cytotoxic 63 EphA2 63 Notch1 63 proteasome inhibitors 63 Enzastaurin 63 multikinase inhibitor 63 cell adhesion molecule 63 PDE# inhibitors 63 BMP2 63 IMP# 63 non nucleoside HCV 63 histone acetylation 63 sphingosine kinase 63 polymerase inhibitor 63 micro RNA 63 ErbB3 HER3 63 TLE3 63 alpha antagonist 63 AFFiRiS 63 polymerase inhibitors 63 Velcade bortezomib 63 midstage clinical 63 DGAT 63 heparanase 63 SOD1 gene 63 ErbB2 positive 63 HER1 63 MAXY VII 63 SYN# 63 retinoid X 63 Stat5 63 IAP inhibitor 63 erlotinib Tarceva 63 GSK3 63 VIPR2 63 PLK1 63 Daclizumab 63 miR #b [002] 63 TGF beta 63 FBPase 63 targeted radiotherapeutic 63 PCSK9 63 KSP inhibitors 63 INCB# [001] 63 IL 1β 63 TRIOLEX 63 lysophosphatidic acid LPA 63 Protexia ® 63 romazarit 63 anti leukemic 63 STAT3 signaling 63 TGF beta1 63 Fibroblast Growth Factor Receptor 63 plasma kallikrein 63 Bezielle 63 molecular biomarkers 63 mGluR4 63 ALS #-# 63 Scancell 63 B lymphocyte stimulator 63 kallikrein 63 humanised antibody 63 Arimoclomol 63 Olaparib 63 LRRK2 63 alpha folate receptor 63 selective antagonists 63 imatinib Gleevec ® 63 epigenetic therapies 63 medulloblastomas 63 inhibit metastasis 63 Hedgehog signaling 63 peptide hormone 63 HER2 overexpression 63 novel VDA molecule 63 DFMO 63 IRAK1 63 deacetylase inhibitors 63 B lymphocyte 63 CB2 selective 63 Li Fraumeni 63 NV1FGF 63 miRagen 63 pharmacologic intervention 63 HuMax CD4 63 Anticalin ® 63 PI3K 63 CRACM 63 EZN 63 S1P 63 antisense inhibition 63 immunoregulation 63 Personalized Immunotherapy 63 peroxisomal 63 PROCHYMAL 63 tumor hypoxia 63 FUS1 63 p#INK#a 63 anti CD# monoclonal 63 Hypoxia Inducible Factor 63 ErbB 63 dacetuzumab 63 p# Shc 63 bFGF 63 FoldRx 63 neuronal nicotinic receptors NNRs 63 TLR3 63 inhibit EGFR 63 mitotic kinesins 63 tumor suppressor protein 63 Amplimexon 63 FAAH 63 Exelixis XL# 63 AEGR 63 GRNVAC1 63 siRNA mediated 63 orally dosed 63 Aliskiren 63 LRAT 63 MDSCs 63 agonist compounds 63 Smurf1 63 generation antisense inhibitor 63 HCV replicon 63 humanized anti 63 CXCR2 63 oral JAK1 63 small molecule agonists 63 PI3K inhibitors 63 Tarvacin Anti Viral 63 ANAVEX #-# [001] 63 c myb 63 Pertuzumab 63 anticancer activity 63 NOX E# 63 Anticalin 63 lymphotoxin 63 Nanobodies 63 Ii protein 63 cytomegalovirus CMV 63 RANK ligand 63 HepDirect prodrug 63 transgenic mouse models 63 neurokinin 1 63 biologic therapies 63 vinca alkaloid 63 sigma receptors 63 Litx 63 samalizumab 63 pleiotropic 63 TÎ ² 4 63 adaptive immunity 63 PIK3CA 63 β catenin 63 Systemic Delivery 63 mutational status 63 plasminogen 63 Flt3 63 potent inhibitor 63 GRP# 63 prostanoid 63 haematopoietic 63 pharmacokinetic interactions 63 HGS# 63 triterpenoids 63 annexin 63 HIF 1a 63 NS4A 63 RANKL 63 Syk kinase 63 casein kinase 63 HER2/neu 63 AQ4N 63 HIF 1alpha 63 Cyclin D1 63 Ceflatonin R 63 glucocorticoid receptor 63 mitogen activated protein kinase 63 cytostatic 63 IGF IR 63 Nedd4 63 favorable pharmacokinetic profile 63 reversible inhibitor 63 XL# XL# 63 Anticalins R 63 PLX cells 63 Doxil ® 63 WT1 63 uricase 63 epigenetic mechanisms 63 Adenosine Therapeutics 63 T#M mutation 63 GED aPC 63 estrogen receptor beta 63 Vitaxin 63 TMEM#B 63 HuMax 63 xenograft models 63 cyclin dependent kinase inhibitor 63 peptibody 62 thyroid hormone receptor 62 binds selectively 62 tumorigenic 62 isotype 62 peptide antigens 62 pancreatic islet 62 RAV# 62 murine monoclonal antibody 62 IGF1R 62 tumor antigens 62 adenosine A2A 62 lintuzumab 62 AVP #D# 62 5 HT6 receptor 62 K RAS 62 cardio renal 62 antibody mediated 62 Nanobody R 62 lupus nephritis 62 NKG2D 62 Stapled Peptide 62 NEUGENE 62 IL# PE#QQR 62 Epizyme 62 thromboxane A2 62 PDE4 62 peptidic 62 PDE#A 62 atrasentan 62 Plicera 62 developing TB4 62 hepatocyte growth 62 anti angiogenic therapy 62 intracellular signaling pathways 62 GPCR targets 62 Apaziquone 62 histone deacetylase HDAC inhibitors 62 Cytotoxic T 62 mesenchymal cell 62 refractory metastatic 62 thrombospondin 62 immunomodulatory effects 62 Carfilzomib 62 Epidermal Growth Factor Receptor 62 angiogenesis inhibitors 62 clusterin 62 HGS ETR1 62 CGEN # 62 immunoconjugate 62 mGluR2 62 Mipomersen 62 Atrasentan 62 PTPN# 62 receptor kinase 62 Curaxin 62 antibody 62 ganetespib 62 antisense compounds 62 inhibit replication 62 cells MSCs 62 neutralizing antibody 62 antisense drugs 62 multiple myeloma MM 62 ligases 62 thymidylate synthase TS 62 interleukin IL -# 62 JUVISTA R Human 62 CCR5 antagonist 62 cyclooxygenase 2 62 potent inhibitors 62 angiogenesis inhibitor 62 axitinib 62 OGG1 62 transgenic rats 62 teplizumab 62 nalbuphine ER 62 imatinib Gleevec 62 PAR1 62 imatinib resistance 62 CXCR4 62 Ridaforolimus 62 TRO# 62 Azedra 62 Sertoli cell 62 B Raf 62 erlotinib Tarceva ® 62 ON #.Na 62 cyclin dependent kinase CDK 62 oxysterols 62 Trophos 62 LRP6 62 IFNs 62 Diamyd ® 62 BRAF mutation 62 PANVAC VF 62 immune modulation 62 vimentin 62 anti EGFR antibody 62 metabolic enzymes 62 ActA 62 beta amyloid peptide 62 receptor inhibitor 62 SRT# [003] 62 IGFBP 3 62 Ocrelizumab 62 MyVax R 62 HuCAL antibodies 62 Kinase inhibitors 62 Phylomer ® 62 ncRNA 62 NOD SCID mice 62 Th2 cytokines 62 autoreactive 62 MORAb 62 TRAIL Receptor 62 drug ISA# 62 Histone deacetylase 62 NY ESO 62 p# mutations 62 S/GSK# 62 Smac mimetic 62 calcineurin 62 mutated KRAS gene 62 CDKs 62 TGF b 62 Vascular Endothelial Growth 62 otelixizumab 62 mineralocorticoid receptor 62 Mcl 1 62 CK2 62 Campath alemtuzumab 62 Fenretinide 62 EndoTAG TM 62 ATG#L# 62 adrenergic regulation 62 A2A receptor 62 ribonucleotide reductase 62 PPAR gamma 62 TNFalpha 62 Hh pathway 62 NPM1 62 HTS assay 62 Ataluren 62 ghrelin receptor 62 liposomal formulation 62 polyclonal antibody 62 EGFR signaling 62 outlicensing 62 hyperphosphorylation 62 AKT1 62 mGluR 62 PEGylated 62 enzyme inhibitors 62 talabostat 62 CCL5 62 NF κB 62 Tß4 62 multi kinase inhibitor 62 VEGFR2 62 small molecule tyrosine 62 inhibiting mTOR 62 mediated inhibition 62 fusion proteins 62 MYDICAR ® 62 Actilon 62 anti angiogenic agent 62 #D#C# 62 mutated K ras 62 immunotherapeutics 62 Romidepsin 62 CXCL# 62 Fas ligand 62 bispecific antibody 62 Pimavanserin 62 potently inhibit 62 hTERT 62 microtubule inhibitor 62 ADI PEG 62 p# biomarker 62 volociximab 62 JVRS 62 NS#/#A protease 62 mitotic kinesin 62 nucleoside 62 FOLOTYN ® 62 nucleoside analogs 62 TGFBR1 * 6A 62 MLN# 62 mGluR5 antagonist 62 IFN gamma 62 PSN# [002] 62 IL 1Ra 62 glucocorticoid receptors 62 Cytolin R 62 serine threonine kinases 62 chemoresistant 62 THR beta agonist 62 prophylactic vaccines 62 lysosomal 62 Src inhibitors 62 USP# 62 mediated apoptosis 62 SIRT3 62 predictive biomarkers 62 LymphoStat B TM 62 FK# 62 interleukins 62 chemoresistance 62 novel anticancer 62 Annamycin 62 MAXY G# 62 REP# 62 allogeneic cell 62 atypical hemolytic uremic syndrome 62 PPARgamma 62 nicotinic acetylcholine receptor 62 OvaRex R 62 humanized monoclonal 62 Vidaza azacitidine 62 OX1 62 cellular cytotoxicity 62 metaglidasen 62 HER2 receptors 62 Monoclonal Antibody 62 ONCONASE R 62 Axiogenesis 62 myogenesis 62 lymphoid organs 62 integrin receptors 62 pediatric acute lymphoblastic 62 Nexavar sorafenib 62 indibulin 62 receptor tyrosine kinase 62 sodium glucose cotransporter 62 apoE 62 Interferon alpha 62 CEACAM1 62 TH# cells 62 targeted antifolate 62 immunotoxins 62 Upregulation 62 selectively inhibited 62 prodrugs 62 fusion protein 62 clinically validated targets 62 cyclin dependent kinase 62 monoclonal 62 Smoothened 62 insulin sensitizers 62 vascular disrupting 62 VEGF 62 costimulatory 62 LymphoStat B belimumab 62 TLR agonists 62 Notch receptor 62 SIRT2